Navigation Links
Moderate Consumption Of Nuts Could Prevent The Risk Of Heart Disease

Doctors are of the opinion that eating nuts about twice a week might reduce the risk of heart disease significantly.//

The study that was presented at the World Congress of Cardiology stated that as little as two servings of eight grams of nuts that would be around a small plate full might reduce the risk of heart disease by as much as 11%.

Another survey confirmed that eating a small quantity of the same kinds of nuts five days a week only results in a little bit of weight gain.

The latest study is part of a larger European study that had begun 10 years ago, to discover the connection between diet, cancer and heart disease. The varieties of nuts that have been included in the study were almonds, walnuts, cashews, Brazilian nuts and traditional peanuts. Yet another study had previously also confirmed that the consumption of a small amount of these same nuts 5 days a week could only cause a very little weight gain.

Professor Elio Riboli, professor of cancer epidemiology at Imperial College, London said, 'You could say that a modest consumption of nuts contributed to reducing myocardial infarction. He did however stated that “But there is no point sitting in front of the TV, being obese and having high blood pressure and expecting nuts to protect you against a heart attack.'
VIK
'"/>




Page: 1

Related medicine news :

1. Moderate Use of Analgesics - Not Associated With Kidney Dysfunction
2. Moderate alcohol consumption protects against dementia
3. Moderate Exercise may not help prevent Heart Disease
4. The Benefits Of A Diet Consisting Of Moderate Amounts Of Fat
5. Moderate drinking can be good for the kidneys
6. Enjoy Moderate Exercise and Keep Your Heart Fit
7. Even Moderate Drinking Is Not Good For The Heart
8. Moderate Drinkers Found to Escape Obesity and Related Problems
9. Moderate Exercise Is Good For The Heart: Study
10. Moderate Drinking Can Help Cut Diabetes Risk In Middle-Aged Women
11. Moderate Drinking Does Not Guard Against Heart Disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2017)... ... 2017 , ... East Los Angeles dentist, Ramin Assili DDS , comments ... happens to a woman during pregnancy can have profound effects on a developing fetus, ... on a baby’s long-term health. This study, which was performed at the University of ...
(Date:6/26/2017)... Torrance, CA (PRWEB) , ... June 26, 2017 , ... ... treatments. Smile aesthetics can be one of the most noticeable aspects of a person’s ... approachable. While not everyone is born with beautiful, balanced teeth, everyone can have the ...
(Date:6/26/2017)... ... June 26, 2017 , ... ... & Sexual Medicine Specialists, in collaboration with the Fertility Center of California, is ... care: PESA (percutaneous epidydimal sperm aspiration) and TESA (percutaneous testicular sperm extraction). These ...
(Date:6/26/2017)... SALISBURY, MD. (PRWEB) , ... June 26, 2017 ... ... their crop, according to a recent review of government data released by the ... continuous improvement in management practices, Maryland’s soybean farmers have increased their productivity on ...
(Date:6/26/2017)... Lake Tahoe, CA (PRWEB) , ... June 26, 2017 , ... ... seeking 10,000 qualified mental health professionals in every state across the country to join ... an easy and rewarding way for therapists to reach a substantially greater number of ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... -- Less than a month ago, amateur hackers executed an ... hospital networks, in over 150 countries. The ... online extortion attempts ever recorded. With the increasing complexity ... that providers understand where the risks lie, and how ... many other very real cyber threats.  ...
(Date:6/7/2017)... GAITHERSBURG, Md. , June 7, 2017  Novavax, Inc., ... the second of two Phase 2 trials of its RSV ... women of child bearing age have been published in the ... this publication have been shared in prior scientific conferences). The ... trial in April 2014. Novavax is developing the RSV F ...
(Date:6/3/2017)... 2017  Eli Lilly and Company (NYSE: ... the Phase 3 MONARCH 2 study showed that ... in combination with fulvestrant, significantly improved progression-free survival ... women with hormone-receptor-positive (HR+), human epidermal growth factor ... relapsed or progressed after endocrine therapy (median PFS, ...
Breaking Medicine Technology: